A prospective comparative study to evaluate the efficacy of nasal
A prospective comparative study to evaluate the efficacy of nasal (GENEDIA W COVID-19 Ag (Ref. 643K)) and nasopharyngeal (GENEDIA W COVID-19 Ag (Ref. 643G)) antigenic rapid tests produced by Green Cross Medical Science Corp, Seoul, South Korea, for the identification of... Read More →
